Anxiety and schizophrenia: Review of research;Anxiété et schizophrénie: Situation actuelle

Annales Medico-Psychologiques

Volumn 158, Issue 10, 2000, Pages 741-749

  Bayle F J ^a   Llorca, P M ^a   Olie J P ^a   Loo H ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Anxiety; Benzodiazepine; Panic attack; Schizophrenia

Indexed keywords

BENZODIAZEPINE;

ANXIETY NEUROSIS; ARTICLE; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISSOCIATION; HUMAN; METHODOLOGY; PANIC; SCHIZOPHRENIA; SYMPTOMATOLOGY;

EID: 0034477634     PISSN: 00034487     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Angoisse psychotique et angoisse névrotique. Différence qualitative ou différence quantitative?
2. The Use of benzodiazepine for psychotic disorders: A literature review and preliminary clinical findings
3. Panic attacks in schizophrenia
4. Aphenomenological study of 90 patients with panic disorder. Part II
5. Comorbidit́e et co-occurence symptomatique
6. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: A neuropsychological study
7. Emerging uses for high-potency benzodiazepines in psychotic disorders
8. Two faces of cholecystokinin: Anxiety and schizophrenia
9. Use of mental health services for the treatment of panic disorder
10. Occurence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders
11. Étude de l'intérêt de l'association du bromazépam à un neuroleptique dans le traitement des troubles anxieux du psychotique
12. Anxiété et psychoses
13. The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder
14. "Panic-like" symptomatology in schizophrenic and schizoaffective patients with postpsychotic depression: Observations and implications
15. Lorazepam in the treatment of severe anxiety and anxiety associated with psychotic conditions
16. Obsessive-compulsive disorder in patients with schizophrenia or schizoaffective disorder
17. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder
18. The prognostic significance of obsessive-compulsive symptoms in schizophrenia
19. Panic attacks with psychotic features
20. Examination of comorbid anxiety in psychiatrics inpatients
21. Comorbidité troubles anxieux et schizophrénies: Aspects épidémiologiques et cliniques
22. Évaluation et classification de l'anxiété paroxystique: À propos d'une recherche clinique
23. Enquête nationale sur l'anxiété Résultats cliniques
24. Relation of schizophrenia and panic disorder: Evidence from a controlled study
25. Relationship beetween panic and schizophrenia
26. Adjunctive alprazolam for schizophrenia with panic anxiety: Clinical observation and pathogenic implications
27. Schizophrenia, panic anxiety, and alprazolam
28. Anxiety in schizophrenia. The responses to chlordiazepoxide in an intensive design study
29. Legitime prevalence, demographic risk factors and diagnostic validity of non-affective psychosis as assessed in a U.S. Community sample
30. Briel report: Risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults
31. Anxiety reconceptualised
32. Les syndromes schizophréniques
33. Les confins de l'anxiété
34. L'anxiété dans les psychoses
35. Les différents états psychotiques
36. Predictive value of early anti-anxiety effects on the acute antipyschotic outcome: A comparison of fluphenazine and olanzapine
37. Negative symptoms: Relationships to other schizophrenic symptom classes
38. The schizophrenic and paranoid disorders
39. Dysphoric mood and symptomatology in schizophrenia
40. Traitement de l'anxiété dans les psychoses chroniques, étude du prazépam: Compte rendu d'une érude multicentrique concernant le prazépam 40 mg en milieu psychiatrique
41. Social anxiety in schizophrenia
42. Différentes modalités d'anxiété. Approche psychométrique
43. Obsessive-compulsive disorder in patients with first-episode schizophrenia
44. CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain dopamine neurons
45. L'effort pour rendre l'autre fou
46. Postpsychotic depression and negative symptoms: An investigation of syndromal overlap
47. APS imipramine-responsive panic-like symptomatology in schizophrenia/schizoaffective disorder
48. Anxiety in schizophrenic psychoses
49. Psychopathologic precursors and sociodemographic risk factors for the schizophrenia syndrome
50. Negative affectivity: The disposition to experience aversive emotional states
51. Benzodiazepines in the treatment of schizophrenia: A review and reappraisal
52. Chapter V, mental and behavioral disorders. Diagnostic criteria for research
53. Schizophrenia, panic attacks, and antidepressants
54. Negative symptoms: Are they indigenous to schizophrenia